Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Liang‐I Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7025-3095; OpenAlex author ID A5035329303; NIH RePORTER profile ID 8951023. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
1
Labs led
1
Collaborators
54
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers, 1 grant

Papers 11

  1. Treg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adz4302↗
  2. Therapeutic reprogramming of tumour-associated macrophages in pancreatic cancer using a cytotoxic CCR2-targeted nanotheranostic. Co-author DOI 10.1186/s12943-026-02597-7↗
  3. Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues. Co-author DOI 10.3389/fonc.2026.1935795↗
  4. Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adp3978↗
  5. HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-2200↗
  6. Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acsptsci.3c00303↗
  7. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-0428↗
  8. Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC. Co-author DOI 10.1038/s41590-023-01579-x↗
  9. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-21-0946↗
  10. IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2022.02.035↗
  11. Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor. First author DOI 10.1097/pas.0000000000001454↗

Grants 1

  1. The role and spatiotemporal dynamics of TREM2+ macrophages in liver metastases of pancreatic ductal adenocarcinoma K08CA308780↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David G DeNardo · 11 shared papers, 2020–2026 · strength 1.97
  2. Ryan C Fields · 5 shared papers, 2023–2025 · strength 0.84
  3. Varintra E. Lander · 4 shared papers, 2022–2025 · strength 0.65
  4. Blake E. Sells · 3 shared papers, 2024–2026 · strength 0.61
  5. Vikas Somani · 3 shared papers, 2022–2026 · strength 0.55
  6. John M. Baer · 3 shared papers, 2023–2024 · strength 0.47
  7. William G. Hawkins · 3 shared papers, 2020–2025 · strength 0.46
  8. Graham D. Hogg · 2 shared papers, 2023–2025 · strength 0.34
  9. Li Ding · 2 shared papers, 2023–2024 · strength 0.32
  10. Kian‐Huat Lim · 2 shared papers, 2022–2024 · strength 0.31
  11. Kameisha V. Rashford · 1 shared paper, 2026 · strength 0.24
  12. Colin T. McDowell · 1 shared paper, 2026 · strength 0.24
  13. Joseph E. Ippolito · 1 shared paper, 2026 · strength 0.24
  14. Richard R. Drake · 1 shared paper, 2026 · strength 0.24
  15. Ashenafi Shiferaw Bulle · 1 shared paper, 2026 · strength 0.24
  16. Sapana Bansod · 1 shared paper, 2026 · strength 0.24
  17. Kian-Huat Lim · 1 shared paper, 2026 · strength 0.24
  18. Ingunn M. Stromnes · 1 shared paper, 2026 · strength 0.22
  19. Adam L. Burrack · 1 shared paper, 2026 · strength 0.22
  20. Zoe C. Schmiechen · 1 shared paper, 2026 · strength 0.22
  21. Cara-lin Lonetree · 1 shared paper, 2026 · strength 0.22
  22. Grant H. Hickok · 1 shared paper, 2026 · strength 0.22
  23. Alexander K. Tsai · 1 shared paper, 2026 · strength 0.22
  24. Nina G. Steele · 1 shared paper, 2025 · strength 0.19
  25. Alyssa G. Weinstein · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.